Holt, Shaun

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Accuracy of references in five leading medical journals

Siebers, R., & Holt, S. (2000) · The Lancet

Academic Writing and Publishingscientometrics and bibliometrics research

Cited by 71

Fel d 1 levels in domestic living rooms are not related to cat color or hair length

Siebers, R., Holt, S., Peters, S., Crane, J., & Fitzharris, P. (2001) · Journal of Allergy and Clinical Immunology

Allergic Rhinitis and SensitizationIndoor Air Quality and Microbial Exposure

Cited by 7